NeuroSense reports 65% death risk reduction in ALS trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY
6. NAVN
7. HUMA
8. NVDA
9. CRWV
10. CME

Go back to NeuroSense reports 65% death risk reduction in ALS trial
(NASDAQ: NRSN) Delayed: 0.87 +0.02 (2.35%)
Previous Close $0.85    52 Week High $ 
Open $0.86    52 Week Low $ 
Day High $0.90    P/E N/A 
Day Low $0.84    EPS $ 
Volume 67,701       

(NASDAQ: NRSNW) Delayed: 0.21 --0 (-0%)
Previous Close $0.21    52 Week High $ 
Open $0.21    52 Week Low $ 
Day High $0.21    P/E N/A 
Day Low $0.21    EPS $ 
Volume 69,564,443